SCHEMBL6664557

SCHEMBL6664557

CNc1nc(N2CCNCC2)nc(N)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
POLB P06746 2/20 0.44
HTR2A P28223 1/20 0.44
APAF1 O14727 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
UBE2N P61088 1/20 0.44
KHK P50053 2/20 0.44
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ROCK2 O75116 1/20 0.39
CASP1 P29466 1/20 0.39
CASP4 P49662 1/20 0.39
CASP5 P51878 1/20 0.39
PLK4 O00444 1/20 0.38
PAK4 O96013 1/20 0.38
HRH4 Q9H3N8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18153315 0.98 HTR2A (0.46) HRH1KDM4EALDH1A1POLBHTR2A
SCHEMBL3236690 0.75 ROCK2 (0.53) ALDH1A1POLBHTR2AKHKSMN1; SMN2
SCHEMBL11203366 0.74 KHK (0.41) HRH1KDM4EALDH1A1POLBHTR2A
SCHEMBL3247675 0.73 NPC1 (0.57) KDM4EALDH1A1POLBMAPTHPGD
SCHEMBL3240367 0.73 SORD (0.40) KDM4EALDH1A1MAPTHRH4KMT2A
SCHEMBL11200575 0.72 ABCB1 (0.47) HRH1KDM4EALDH1A1POLBAPAF1
SCHEMBL7161387 0.71 CASP1 (0.51) KDM4EPOLBMAPTCASP1CASP4
SCHEMBL11201723 0.71 KHK (0.39) HRH1KDM4EALDH1A1HTR2AKHK
SCHEMBL24325504 0.71 HRH1 (0.61) HRH1KDM4EALDH1A1POLBMAPT
SCHEMBL9488077 0.70 HRH1 (0.59) HRH1KDM4EALDH1A1POLBAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212327-B8 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2004-02-25 EP disclosed
WO-2004014307-A2 GAL3 ANTAGONISTS FOR THE TREATMENT OF NEUROPATHIC PAIN SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-02-19 WO disclosed
EP-1212327-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2002-06-12 EP disclosed
WO-2001019829-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed